| ZNF7 - Zinc Finger Protein 7 | |
|---|---|
| Symbol | ZNF7 |
| Full Name | Zinc Finger Protein 7 |
| Chromosome | 8q24.21 |
| NCBI Gene ID | [7553](https://www.ncbi.nlm.nih.gov/gene/7553) |
| OMIM | [194538](https://www.omim.org/entry/194538) |
| Ensembl | [ENSG00000124783](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000124783) |
| UniProt | [P17026](https://www.uniprot.org/uniprot/P17026) |
| Also Known As | KOX15, ZNF45 |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Cancer |
ZNF7 (Zinc Finger Protein 7), also known as ZNF45 or KOX15, is a C2H2-type zinc finger transcription factor that belongs to the Krüppel-associated box (KRAB) family [1]. The KRAB-ZNF gene family represents one of the largest families of transcriptional regulators in mammals, with over 400 members in humans. ZNF7 functions primarily as a transcriptional repressor and plays roles in development, cell differentiation, and potentially in neurodegenerative disease processes.
ZNF proteins are characterized by their zinc finger domains, which mediate DNA binding, and the KRAB domain, which confers transcriptional repression activity. The KRAB domain recruits co-repressor complexes that modify chromatin structure and silence gene expression [2].
The ZNF7 gene spans approximately 12 kb on chromosome 8q24.21 and encodes a protein of approximately 650 amino acids. The gene structure is typical of KRAB-ZNF proteins:
The ZNF7 gene has been conserved throughout vertebrate evolution, reflecting its fundamental biological functions. The KRAB-ZNF family has expanded significantly in mammals, particularly in primates, suggesting roles in species-specific regulatory networks [3].
ZNF7 functions as a transcriptional repressor through multiple mechanisms:
ZNF7 has been implicated in regulating various target genes, though specific direct targets in neurons remain incompletely characterized:
The broad DNA-binding specificity of ZNF proteins suggests that ZNF7 may regulate multiple gene networks, making precise target identification challenging [5].
| Partner | Interaction | Function |
|---|---|---|
| KAP1/TRIM28 | Direct binding | Co-repressor complex |
| HDAC1/2 | Via KAP1 | Histone deacetylation |
| SUV39H1 | Via KAP1 | H3K9 methylation |
| Other ZNFs | Dimerization | DNA binding specificity |
ZNF7 exhibits tissue-specific expression patterns:
In the brain, ZNF7 expression is detected in:
The expression of ZNF7 in neuronal populations suggests potential functions in neural development and maintenance [6].
ZNF7 and other KRAB-ZNF proteins have been implicated in Alzheimer's disease pathogenesis through several mechanisms [7]:
In Parkinson's disease, ZNF7 may play roles in:
The KRAB-ZNF family is the largest family of transcriptional regulators in mammals. Key characteristics [9]:
Recent studies have highlighted the importance of ZNF proteins in neurodegenerative diseases [10]:
Direct targeting of ZNF7 for therapeutic purposes remains challenging:
| Approach | Strategy | Status |
|---|---|---|
| Epigenetic drugs | HDAC inhibitors | Clinical trials |
| Gene expression modulation | Transcriptional regulators | Research |
| RNA interference | siRNA/shRNA | Preclinical |
| CRISPR targeting | Epigenetic editing | Investigational |
The broad functions of KRAB-ZNF proteins in transcriptional regulation suggest that selective modulation would be required to avoid off-target effects [11].
Key questions about ZNF7 in neurodegeneration remain: